MAP has been informed that Adam Anderson has been appointed as the Head of NHS England and NHS Improvement’s Commercial Medicines Unit (CMU) from 1st September.
This role reports to Commercial Medicines Director Blake Dark, making Mr Anderson an important stakeholder in future dealings with the NHS. As Head of CMU, Mr Anderson will oversee its role in the procurement and supply chains of hospital medicines at a national level.
“Adam, who will be leading and developing the CMU both strategically and operationally to ensure it continues to meet the needs of an ever-changing NHS, from the private sector and has held various commercial board level positions. He brings with him a strong track record of strategic commercial improvement combined with excellent leadership and negotiation skills.”
MAP is grateful to EMIG, the Ethical Medicines Industry Group, for alerting us to this appointment.